Page 64 - HOH

MEDICAL ONCOLOGIST LUDIMILA

CAVALCANTE, M.D., MSCI, JOINS MIAMI

CANCER INSTITUTE

7 HORA PASA , 26 DI MAART 2019 14:36
SECCION: INTERNATIONAL

MIAMI – March 4, 2019 — Miami Cancer Institute, a part of Baptist Health South Florida and the

state’s only member of the Memorial Sloan Kettering Cancer Alliance, welcomes medical
oncologist and clinical researcher Ludimila Cavalcante, M.D., MSCI, to its team of
multidisciplinary cancer care specialists. Double boarded in Internal Medicine and Medical
Oncology, Dr. Cavalcante specializes in the treatment of sarcoma and melanoma, and in early

drug development.

Dr. Cavalcante earned her medical degree at Universidade Federal do Estado do Rio de
Janeiro in Brazil. She completed a residency in internal medicine at Mount Sinai Medical Center
in Miami Beach and two fellowships — one in medical/oncology at the University of Wisconsin
School of Medicine in Madison, Wis., and the other in developmental therapeutics at the

Northwestern University Feinberg School of Medicine.

Dr. Cavalcante will be actively involved in patient care, clinical trials and early drug development
in our Precision Medicine Unit, the latter under the tutelage of Deputy Director and Chief

Scientific Officer of Miami Cancer Institute, Dr. Miguel Villalona. She is a member of several